ArticleFrontiers in oncology2022

Efficacy and safety of bevacizumab biosimilar compared with reference bevacizumab in locally advanced and advanced non-small cell lung cancer patients: A retrospective study.

Zhiting Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.